This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Diabetes Mellitus During Olanzapine and Quetiapine Treatment in Japan

Dan Cohen, MD

Published: February 15, 2005

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: In their report "The Incidence of Hyperglycemia in Patients Treated With Olanzapine," Misawa et al.1 present very interesting but also very disturbing data on dysregulation of glucose metabolism associated with treatment of 2 atypical antipsychotics, olanzapine and quetiapine. I would like to comment on some aspects of their report. Misawa et al. report that within 10 months after the introduction of olanzapine in Japan, 9 schizophrenic patients were reported to have developed severe diabetes mellitus and diabetic coma, resulting in 2 deaths.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 66

Quick Links: